939 related articles for article (PubMed ID: 9015217)
1. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
2. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
4. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
7. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
9. A simple and quantitative liquid culture system to measure megakaryocyte growth using highly purified CFU-MK.
Miyazaki H; Horie K; Shimada Y; Kokubo A; Maeda E; Inoue H; Kato T
Exp Hematol; 1995 Oct; 23(11):1224-8. PubMed ID: 7556534
[TBL] [Abstract][Full Text] [Related]
10. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant interleukin-6 and thrombopoietin on isolated guinea pig bone marrow megakaryocyte protein phosphorylation and proplatelet formation.
Leven RM; Clark B; Tablin F
Blood Cells Mol Dis; 1997 Aug; 23(2):252-68. PubMed ID: 9410469
[TBL] [Abstract][Full Text] [Related]
12. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
14. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
Miyazaki H; Inoue H; Yanagida M; Horie K; Mikayama T; Ohashi H; Nishikawa M; Suzuki T; Sudo T
Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
16. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes.
Schattner M; Lefebvre P; Mingolelli SS; Goolsby CL; Rademaker A; White JG; Foster D; Green D; Cohen I
Stem Cells; 1996 Mar; 14(2):207-14. PubMed ID: 8991540
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
